financetom
Business
financetom
/
Business
/
Hydraulics maker Helios' Q3 sales rise 13% beating analyst expectations
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hydraulics maker Helios' Q3 sales rise 13% beating analyst expectations
Nov 3, 2025 1:34 PM

Overview

* Helios Q3 sales grow 13% yr/yr, beating analyst expectations

* Adjusted EPS for Q3 beats consensus, reflecting improved operational performance

* Company reduced debt by $64 mln, improving net debt-to-EBITDA leverage ratio

Outlook

* Helios anticipates FY25 adjusted EBITDA margin of 19.1%-19.4%

Result Drivers

* SALES GROWTH - Hydraulics segment sales increased 9% driven by mobile and agriculture markets

* ELECTRONICS DEMAND - Electronics segment sales rose 21% due to growth in recreational, mobile, and industrial markets

* GROSS MARGIN EXPANSION - Gross margin expanded 200 bps due to higher volume and lower direct labor costs

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Sales Beat $220.3 $211.30

mln mln (5

Analysts

)

Q3 Beat $0.72 $0.66 (5

Adjusted Analysts

EPS )

Q3 Net $10.3

Income mln

Q3 Beat $45.10 $42.60

Adjusted mln mln (5

EBITDA Analysts

)

Q3 Gross 33.10%

Margin

Q3 $1.30

Operatin mln

g income

Analyst Coverage

* The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the industrial machinery & equipment peer group is "buy."

* Wall Street's median 12-month price target for Helios Technologies Inc ( HLIO ) is $58.00, about 4.6% above its October 31 closing price of $55.36

* The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 17 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
More than 340,000 customers without power in Louisiana due to storm Francine
More than 340,000 customers without power in Louisiana due to storm Francine
Sep 12, 2024
(Adds Entergy statement in paragraph four, updates latest figures) Sept 12 (Reuters) - Over 340,000 homes and businesses in Louisiana were left without power on Thursday after Hurricane Francine barrelled onto the state's Gulf Coast, according to data from PowerOutage.us. Francine abated to a tropical storm earlier in the day, but not before it pounded southeast Louisiana and southern Mississippi...
US FDA Authorizes First OTC Hearing Aid Software for Apple's AirPods Pro
US FDA Authorizes First OTC Hearing Aid Software for Apple's AirPods Pro
Sep 12, 2024
12:08 PM EDT, 09/12/2024 (MT Newswires) -- The US Food and Drug Administration said Thursday it has authorized the first over-the-counter hearing aid software device, Hearing Aid Feature, that is intended to be used with compatible versions of the Apple ( AAPL ) AirPods Pro headphones. The Hearing Aid Feature enables compatible versions of the AirPods Pro to serve as...
Update: Moderna to Cut Annual R&D Spending by $1.1 Billion From 2027
Update: Moderna to Cut Annual R&D Spending by $1.1 Billion From 2027
Sep 12, 2024
08:33 AM EDT, 09/12/2024 (MT Newswires) -- (Updates with additional information in third to seventh paragraphs.) Moderna ( MRNA ) said Thursday it is reducing its annual R&D expense by about $1.1 billion starting in 2027 in light of recent commercial challenges. The company now expects 2025 revenue of $2.5 billion to $3.5 billion. Analysts polled by Capital IQ expect...
China's Ant Group refinancing $6.5 billion credit line
China's Ant Group refinancing $6.5 billion credit line
Sep 12, 2024
(Reuters) - China's Ant Group, backed by Alibaba founder Jack Ma, is refinancing a credit line of $6.5 billion, a company spokesperson said on Thursday. This was a refinancing of an existing syndicated bank credit line from 2019, the spokesperson added. (Reporting by Deborah Sophia in Bengaluru and Casey Hall in Shanghai, Editing by Anil D'Silva) ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved